Sb Investment Advisers (Uk) LTD Vir Biotechnology, Inc. Transaction History
Sb Investment Advisers (Uk) LTD
- $12.6 Billion
- Q2 2025
A detailed history of Sb Investment Advisers (Uk) LTD transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 16,684,041 shares of VIR stock, worth $83.4 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
16,684,041
Previous 16,684,041
-0.0%
Holding current value
$83.4 Million
Previous $108 Million
22.22%
% of portfolio
0.67%
Previous 0.99%
Shares
6 transactions
Others Institutions Holding VIR
# of Institutions
243Shares Held
109MCall Options Held
342KPut Options Held
150K-
Black Rock Inc. New York, NY16.4MShares$82.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$66.1 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL12.9MShares$64.6 Million34.47% of portfolio
-
State Street Corp Boston, MA5.25MShares$26.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.46MShares$17.3 Million0.0% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $663M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...